In this paper, we propose a mathematical model for HIV infection with delays in cell infection and virus production. The model examines a viral therapy for controlling infections through recombining HIV with a genetically modified virus. For this model, we derive two biologically insightful quantities (reproduction numbers) R 0 and R z , and their threshold properties are discussed. When R 0 < 1, the infection-free equilibrium E 0 is globally asymptotically stable. If R 0 > 1 and R z < 1, the single-infection equilibrium E s is globally asymptotically stable. When R z > 1, there occurs the double-infection equilibrium E d , and there exists a constant R b such that E d is asymptotically stable if 1 < R z < R b . Some simulations are performed to support and complement the theoretical results.
In this paper, we propose a mathematical model for HIV infection with delays in cell infection and virus production. The model examines a viral therapy for controlling infections through recombining HIV with a genetically modified virus. For this model, we derive two biologically insightful quantities (reproduction numbers) R 0 and R z , and their threshold properties are discussed. When R 0 < 1, the infection-free equilibrium E 0 is globally asymptotically stable. If R 0 > 1 and R z < 1, the single-infection equilibrium E s is globally asymptotically stable. When R z > 1, there occurs the double-infection equilibrium E d , and there exists a constant R b such that E d is asymptotically stable if 1 < R z < R b . Some simulations are performed to support and complement the theoretical results.
Introduction
Acquired immune deficiency syndrome (AIDS) was first recognized by the United States Centers for Disease Control and Prevention in 1981 [1] . AIDS is caused by infection with human immunodeficiency virus (HIV), which is transmitted primarily via unprotected sexual contact, contaminated blood transfusions, hypodermic needles and from mother to child during pregnancy, delivery or breastfeeding. With no cure or vaccine in sight, HIV disease continues to be a serious health issue for parts of the world. According to the report [2] by UNAIDS, there were approximately 36.9 (34.3-41.4) million people living with HIV around the world at the end of 2014, and 1.2 (1.0-1.5) million people died from HIV-related causes in 2014. For more information about AIDS, we refer the reader to [1] [2] [3] and references therein. As its name suggests, AIDS causes deficiency of the human immune system, making people infected by HIV more susceptible to common infections that do not usually affect people with a working immune system, because the number of CD4 + T cells declines below a centre critical level owing to HIV infection. The entry of HIV into CD4 + T cells begins with the interaction between gp120 on its surface with receptor CD4, and coreceptors CCR5 and CXCR4 on the target membrane. Then, the tips of gp41 are inserted into the target membrane, and viral and cellular membranes fuse together [4] . After HIV has bound to the target cell, the HIV RNA and various enzymes are injected into the cell, including reverse transcriptase and integrase. Reverse transcriptase copies the positive single-stranded RNA genome into a complementary DNA molecule, which together with its complement forms a double-stranded viral DNA. The viral DNA is then transported into the cell nucleus, and is integrated into the host cell's genome by another viral enzyme integrase [5] . To produce the virus, the integrated DNA provirus is transcribed into mRNA, and viral proteins are produced by translation of mRNA. Viral genome and proteins assemble together, bud out of the host cell, and a mature HIV virion is produced. During viral replication, CD4 + T cells infected with HIV are killed. For the mechanism of CD4 + T cell death in HIV infection, see [6, 7] .
A general model system for HIV infection is described by the following differential equationṡ
x(t) = λ − dx(t) − f (x(t), v(t)),
andv(t) = ke −a 2 τ 2 y(t − τ 2 ) − pv(t),
where
x(t), y(t), v(t) is the density of virus-free host cells (mostly corresponding to CD4 + T cells)
, infected cells and the free HIV at time t, respectively. In the model (1.1), the healthy host cells are assumed to be produced at rate λ, and to die at rate d per cell. Host cells are contacted by the virus at rate f (x, v). It is assumed that it takes an average time τ 1 for the contacting virions to enter cells, which means that the contacted cells become actively affected. Then, after an average time τ 2 , the infected cells start to create and release new virions at rate k. The death rate for infected cells and free virus is a 1 and p, respectively. The death rate factor for the latent period and the virus production period is e −a 1 τ 1 and e −a 2 τ 2 , respectively. Realistically, a 2 may differ from a 1 . The simplest and earliest form of system (1.1) was derived in [8, 9] , where f (x, v) = βxv, τ 1 = τ 2 = 0. The corresponding basic reproduction number R 0 was identified in [10, 11] , and it was proved that when R 0 < 1, the disease-free equilibrium is globally asymptotically stable, and when R 0 > 1, the disease-free equilibrium becomes unstable, and the infection equilibrium is globally asymptotically stable. When delays are added into the modelling, e.g. [12] [13] [14] , it has been shown that ignoring delays leads to overestimation of the basic reproduction number. Besides the bilinear incidence rate f (x, v) = βxv, nonlinear incidence rates were also studied, for instance the saturated incidence rate f (x, v) = βxv/(1 + b 1 v) in [15] [16] [17] , and the Beddington-DeAngelis infection rate [18] [19] [20] [21] . For the models mentioned above with these specific nonlinear incidence rates, the corresponding basic reproduction number was identified and its threshold property was discussed.
Based on model (1.1), various HIV models are developed to investigate drug resistance, immune responses and effects of antiretroviral therapy. These researches have contributed to the understanding of HIV biology [22] . We focus on an HIV virotherapy, which is offered by generic engineering to control HIV infections via introducing recombinant virus [23] [24] [25] . One application of genetically modified viruses is cell targeting. For instance, the so-called reverse genetics systems can be used to recover rhabdoviruses from cDNA, which makes it possible to genetically engineer rhabdoviruses [23] . In this case, the recombinant virus is targeted to cells infected by HIV, because the recombinant virus is capable of infecting and killing CD4 + T cells previously infected by HIV, and does no harm to healthy cells. For example, in [25] , a recombinant vesicular stomastitis virus lacking the glycoprotein gene and expressing CD4 and CXCR4 is developed with the property that this virus is unable to infect normal cells, and the cells first infected with HIV-1 are rapidly superinfected with this virus, and killed before high levels of HIV-1 are released.
To model the virotherapy, we add the recombinant virus w and double-infected cells z into system (1.1), and propose the following model
In the model (1.2), the cells previously infected by HIV (single-infected cells) are infected by recombinant virus at a rate αwy, before turning into double-infected cells. Double-infected cells die at a rate bz and release recombinant virus at rate c per cell. The death rate of recombinant virus is q. We assume that the recombinant virus infection is much faster than HIV infection. So delays are not considered for z or w in this model. To the best of our knowledge, only the case f (x, v) = βxv has been considered in the literature, such as [26, 27] . In [26, 27] , the corresponding ordinary differential system of (1.2) was studied. Only the structure of the equilibria was analysed in [27] , and some numerical simulations were presented. The authors in [26] gave a dynamical analysis on the stability of all three equilibria. The effects of delay τ 1 on the dynamical behaviour were investigated in [28] .
In model (1.2), we suppose that the incidence rate depends on x and v, and is given by a continuous function f (x, v) with continuous derivatives. To be biologically feasible, f (x, v) must satisfy the conditions
for all x, v > 0. For the biological meaning, the first two conditions (1.3) and (1.4) are obvious. The third one (1.5) means that the incidence rate is a concave function with respect to the number of free HIV. That could be realistic, because when the number of free HIV is so high that any host cells in contact with HIV is virtually certain, the incidence rate will respond more slowly than linearly to the increase in v. Our main goal in this paper is to study the impact of two time delays on lowering the HIV load and increasing the CD4 + T cell count. We obtain two reproduction numbers R 0 and R z for (1.2), and discuss their threshold properties. As a corollary of the main results in this paper, we prove the threshold property of the corresponding basic reproduction number for system (1.1) with the general incidence rate f (x, v).
The rest of this paper is organized as follows. In §2, for system (1.2), we will discuss the well-posedness of the solutions, and the existence of different equilibria. In addition, in order to properly define biologically meaningful equilibria, two reproduction numbers R 0 and R z will be defined. In § §3-5, we analyse the stability of the three equilibria: disease-free equilibrium E 0 , single-infection equilibrium E s and double-infection equilibrium E d . It will be shown that E 0 is globally asymptotically stable for R 0 < 1, E s is globally asymptotically stable for R 0 > 1 and R z < 1, and E d is asymptotically stable for 1 < R z < R b , where R b is a number larger than 1. A numerical example is presented in §6 to demonstrate the theoretical predictions and to show Hopf bifurcation at E d . Finally, conclusion and discussion are drawn in §7. 
Well-posedness and existence of equilibrium points
We introduce the Banach space X = C([−τ , 0]; R 5 + ) equipped with the sup-norm, where τ = max{τ 1 , τ 2 }. We let x t ∈ X be defined by
. It is biologically reasonable to consider initial conditions φ ∈ X for system (1.2). Using the fundamental theory of functional differential equations [29] , we have that there is a unique solution x(t, φ) = (x(t, φ), y(t, φ), v(t, φ), z(t, φ), w(t, φ)) to system (1.2) with x(0, φ) = φ. Theorem 2.1 establishes the non-negativity and boundedness of solutions to (1.2). Theorem 2.1. Let x(t, φ) be a solution of system (1.2) satisfying x(0, φ) = φ ∈ X. Then, x(t, φ) is nonnegative and uniformly bounded for t ≥ 0. More precisely, we have Proof. System (1.2) can be rewritten asẋ(t) = F(x t ), where
It is easy to see that for any φ ∈ X, φ i (0) = 0 for some i, we have F i (φ) ≥ 0. Therefore, according to theorem 2.1 in [30, ch. 5], we know that x(t, φ) ≥ 0 for all t ≥ 0 in its maximal interval of existence. For the boundedness of the solution, we define
Differentiating B(t) with respect to time along the solution of (1.2) yields Because of the boundedness of the solution, the semiflow Φ(t) = x t (·) of system (1.2) is point dissipative. By [31, theorem 3.6 .1], Φ(t) is compact for any t > τ. On the basis of theorem 3.4.8 in [32] , we obtain that Φ(t) has a compact global attractor in X. The proof of the theorem is completed.
Next, we address the basic reproduction number for the model system (1.2) by the nextgeneration operator approach [33, 34] . It is easy to see that system (1.2) has a disease-free equilibrium E 0 = (x 0 , 0, 0, 0, 0), where x 0 = λ/d. Linearizing the system at E 0 , we obtain the following two disease-related equations for variables y and v
Denote u 1 and u 2 be the number of infected cells and HIV at time t = 0, respectively. Then, the remaining numbers of infected cells and HIV at time t are given by
The total numbers of newly infected cells and produced HIV arē
which can be rewritten as
Then, the matrix M 0 is the next infection operator. As usual, the spectral radius of M 0 is called the basic reproduction number R 0 , which is
gives the average number of virions caused by one virion, where (k/p)e −a 1 τ 1 is the mean number of host cells infected by each virion, and (e −a 2 τ 2 /a 1 )f v (x 0 , 0) is the average number of HIV virions produced by one single-infected cell. Now, we want to find the other equilibria of system (1.2), beside the disease-free equilibrium point E 0 . From the last three equations in (1.2), we get
The first equation in (2.3) yields (i) w = 0 or (ii) y = (bq)/(cα).
(i) If w = 0, then z = 0, and the first two equations in (1.2) yields
and
First, we consider the case R 0 < 1. If there exists a positive solution (x, v) in (2.4) and (2.5), then 0 ≤ x < x 0 from (2.4). Further, we can show that F(x, v) < 0 for 0 ≤ x < x 0 and v > 0. In fact, from
and 
Therefore, when R 0 < 1, equations (2.4) and (2.5) do not have positive solutions, which means no equilibrium points.
For the case R 0 > 1, we shall prove that there exists a function x = h(v) satisfying (2.5), and h (v) ≥ 0. Then that proving the existence of positive solutions (x, v) for (2.4) and (2.5) is converted to showing that the curve x = h(v) intersects with the straight line L : (2.4) , as shown in figure 1 .
We first show h (v) ≥ 0 when x = h(v) exists. Noting that, from the mean value theorem, for any x and v > 0 there exists v * ∈ (0, v) such that
Then, substituting (2.6) into (2.5) yields
Hence, from (1.5), we have
for any x and v satisfying x = h(v). On the other hand, from (2.5), we have
To prove the existence of function
In order to make sure that the curve x = h(v) can intersect with the straight line L, we still need to study the maximal interval of existence for the function
Hence, the function x = h(v) can be extended to interval (0, ε + δ). Using this process repeatedly, we can find the maximal interval (0, N) for x = h(v). Denote x * = lim v→N − h(v). Then, from the argument above, we can see at least one of x * or N is infinite.
Then, we claim that if R 0 > 1, there must exist a unique intersection point (v s , x s ) in figure 1 for the curves defined by (2.4) and (2.5). Therefore, if R 0 > 1, then a single-infection equilibrium E s = (x s , y s , v s , 0, 0) exists, where y s = (p)/(ke −a 2 τ 2 )v s , x s and v s satisfy equations (2.4) and (2.5).
(ii) Next, we consider the case y = (bq)/(cα) y d and w > 0. Let 
From the first equation in (2.9), we see that w > 0 if and only if g 1 (x, 0) > 0, which yields
Note that g 2 (x) is a decreasing function in x, and g 2 (0) = λ > 0. Then, equations in (2.9) have positive solutions satisfying (2.10) if and only if M > 0 and
Before we simplify the condition (2.11), we shall first show that equilibrium E s exists when (2.11) holds. From (1.3) and the mean value theorem in multiple variables, there exists θ ∈ (0, 1) such that 12) where
) and (2.12), we can obtain R 0 > R 1 , where
From (1.3) and (1.4), we get f vx (x, 0) ≥ 0, and further with (1.
On the other hand, (2.11) could be rewritten as
Comparing (2.14) with (2.4) and (2.5), from figure 1, we see that the point (v d , M) satisfying (2.14) is on the straight line L and above the curve x = h(v), which means that (2.11) is equivalent to
Hence, R z > 1 is equivalent to condition (2.11). We also can see that R z > 1 implies M > 0, because
Therefore, if and only if R z > 1, then (2.9) has only one positive solution (x d , w d ) for (x, w), and system (1.2) has a double-infection equilibrium For the biological meaning of R z , we rewrite R z = c/q · αy s /b, because y d = (bq)/(cα). It is easy to see that c/q is the average number of recombinant virus that a double-infected cell produces, and αy s /b gives the mean number of double-infected cells caused by each recombinant virus when the number of single-infected cells stabilizes at y s . Then, R z is the average number of recombinant virus caused by one recombinant virus.
Obviously, as 
Global stability of equilibrium E 0
Here, we shall study the global stability of the disease-free equilibrium point E 0 . We have the following theorem. Proof. First, we recall that E 0 is the only equilibrium when R 0 < 1. To prove the global stability of E 0 , we construct the following Lyapunov function:
Then, the derivative of V 0 with respect to time t along the solution of system (1.2) can be expressed as
From (1.5) and (2.6), we see
Hence, dV 0 /dt| (1.2) ≤ 0 and the equality holds for x = x 0 , v = w = 0. Thus, by LaSalle's invariance principle [35] , we conclude that E 0 is globally asymptotically stable. For the unstability of E 0 , we have the linearized system of (1.2) at E 0 given bẏ
for which the characteristic equation is
Obviously, for the local stability of E 0 , it suffices to only consider the zeros of the following function
which means that there exists at least one positive real root for (3.1). Therefore, if R 0 > 1, the infection-free equilibrium E 0 is unstable.
Global stability of the single-infection equilibrium E s
From the analysis given in §2, we know the single-infection equilibrium E s = (x s , y s , v s , 0, 0) exists when R 0 > 1. Before we discuss the global stability of E s , we have the following persistence result. Proof. By the form of system (1.2), it is easy to see that X 0 is positively invariant. We set M ∂ = {φ ∈ X : Φ(t)φ ∈ ∂X 0 , ∀t ≥ 0}. Clearly, M ∂ = {φ ∈ X : φ 2 (0) = 0, φ 3 (0) = 0}.
We claim that W s (E 0 ) ∩ X 0 = ∅. Assume that, on the contrary, there exists ψ ∈ X 0 such that lim t→∞ Φ(t)ψ = E 0 . Then, for any sufficiently small ε > 0, there exists a positive constant T 0 = T 0 (ε), such that for x(t, ψ) we have x(t) > x 0 − ε, v(t) < ε and w(t) < ε for all t ≥ T 0 . Here, because R 0 > 1, we can choose ε small enough such that
Furthermore, when t ≥ T 0 + τ 1 , for x(t, ψ), we have
.5) and (2.6). (4.2)
Consequently, for t ≥ T 0 + τ 1 , from (4.2), we havė
Suppose ξ 0 is the principal eigenvalue of the following linear cooperative systeṁ
Through computing the characteristics polynomial and using (4.1), we find that the origin is a saddle point in the corresponding ordinary differential equations of system (4. 
1 (0, ∞) ⊂ X 0 and p 1 (Φ(t)φ) > 0 if either p 1 (φ) = 0 and φ ∈ X 0 , or if p 1 (φ) > 0. Thus, p 1 is a generalize distance function for the solution semiflow Φ(t) [36] . We obtain that E 0 is a compact and isolated invariant sets in ∂X 0 , and x∈M ∂ ω(x) ⊂ E 0 . Furthermore, no subset of E 0 forms a cycle in ∂X 0 . From the claim above, E 0 is isolated in X, and W s (E 0 ) ∩ X 0 = ∅. By [36, theorem 3] , it follows that there exists η > 0 such that lim inf t→∞ p 1 (Φ(t)φ) ≥ η for all φ ∈ X 0 , which implies Φ(t) is uniformly persistent with respect to (X 0 , ∂X 0 ). Thus, we have ω(φ) ⊂ X 0 for any φ ∈ X 0 .
Further, we have the following result of the global stability at E s . 
Proof. We construct the Lyapunov function
Note that E s satisfies the following relations
Using the above equalities, we have
, 
Furthermore, we know that f (x, v) is a concave function in v from (1.5). Then for any v > 0 and any
From the above inequalities and (1.
The following inequality (1.2) ≤ 0 when R z < 1, and the equality holds when x = x s , y = y s , v = v s and w = 0. Then by LaSalle's invariance principle [35] , we conclude that E s is globally asymptotically stable when R 0 > 1 and R z < 1.
When R z > 1, for the local unstability of E s , we calculate the linearized system of (1.2) at E s , and obtainẋ
z(t) = −bz(t) + αy s w(t) anḋ w(t) = cz(t) − qw(t).
Then, the characteristic equation is given by D 1 (ξ )D 2 (ξ ) = 0, where
Because the quadratic polynomial D 1 (ξ ) in ξ can be expanded as
it is easy to see that D 1 (ξ ) = 0 has two zeros with negative real part if and only if R z < 1. When R z > 1, D 1 (ξ ) has two real roots with different signs. Therefore, E s is unstable if R z > 1.
From the proof of theorems 3.1 and 4.2, it is easy to get the following corollary. 
Stability of the double-infection equilibrium E d
The double-infection equilibrium E d comes into existence for R z > 1. To discuss the local stability of E d , for any quantity A involving τ 1 and τ 2 in the paper, we denote by Proof. First, we recall that E d exists if and only if R z > 1. The linearized system of (1.
where By straightforward but tedious algebraic manipulations, we obtain the characteristic equation of (5.1), given by
The necessary and sufficient conditions for all zeros of (5.3) to have negative real part are given by
Then, we need only to check the signs of i , i = 2, 3, 4, because C 0 > 0 and C 4 > 0. But it is not easy to determine them for general
Hence, we use a continuity argument here. When R z = 1 or where 
Therefore, all roots of (5.3) have negative real part when
If at least one of τ i = 0 for i = 1, 2, it is easy to see ξ = 0 is not a zero of (5.2) because A 0 > 0. Moreover, there are no roots for (5.2) existing as ξ → ∞, because lim sup{|Q 3 (ξ )/P 4 (ξ )| : |ξ | → ∞, Re ξ ≥ 0} < 1 (see [37] ), where
Because all roots of (5.2) continuously depend on τ 1 and τ 2 , the only possibility that the roots of (5.2) enter into the right half plane is to cross the imaginary axis as τ 1 and τ 2 increase. Suppose a purely imaginary number ξ = i , ( > 0), is a root of (5.2). Then substituting
Computing the modulus on the both sides gives H( 2 )
Clearly, h 1 > 0 and h 5 > 0. For h i , i = 2, 3, 4, we use the continuity argument again, and have
. . , 5, which implies that H( 2 ) does not have any positive real roots. Therefore, combining with the condition 1 < R z < R , let R b = min{R , Rb}, then for any R z ∈ (1, R b ), the roots of (5.2) stay in the left half complex plane and E d is locally asymptotically stable.
Besides the local stability of E d , we have the following uniform persistence result with respect to the recombinant virus and double-infected cells. By a similar argument as that in the proof of theorem 4.1, we can show that when
Again, assume that on the contrary, there exists ψ ∈ Y 0 such that lim t→∞ Φ(t)ψ = E s . Then for any sufficiently small ε > 0, there exists a positive constant T 1 = T 1 (ε), such that y(t) > y s − ε for all t ≥ T 1 . Here, because R z > 1, we can choose ε small enough such that
It is easy to see that the following linear systeṁ 
, and
where Φ 1 (t) is the solution semiflow associated with system (1.1). From corollary 4.3, we have that ω 1 is eitherẼ 0 orẼ s . Hence,
Define a continuous function p 2 :
, and p 2 is also a generalize distance function for the solution semiflow Φ(t). From the proof above, we conclude that any forward orbit of Φ(t) in N ∂ converges to E 0 or E s , that E 0 and E s are two isolated invariant sets in X, and (W s (E 0 ) ∩ W s (E 1 )) ∪ Y 0 = ∅. Moreover, it is easy to see that no subset of {E 0 , E s } forms a cycle in ∂Y 0 . By [36, theorem 3] , it follows that there exist η > 0 such that lim inf t→∞ p 2 (Φ(t)φ) ≥ η for all φ ∈ Y 0 , which implies Φ(t) is uniformly persistent with respect to (Y 0 , ∂Y 0 ).
Numerical simulations
In the above discussions, owing to the general form of f (x, v), we cannot obtain the explicit form of R z . Consequently, we are not able to either prove the global stability of the third equilibrium point E d or determine whether there are other dynamic phenomena around E d for R z > 1. So in this section, using numerical simulation we show some dynamical behaviour around E d , including the convergence of orbits to E d and the existence of Hopf bifurcation for system (1.2).
Because there are more parameters involved in the model if a nonlinear incidence function is used, we cannot find the proper value range for the new parameter in the literature. A non-reliable parameter value could damage the biological interpretation of the numerical simulations. So we chose a bilinear incidence function f (x, v) = βxv, where β is the constant rate at which a T cell is contacted by the virus, which is widely used in other papers. Then R 2 0 = (kβλ)/(a 1 dp)e −a 1 τ 1 −a 2 τ 2 and R z = (αcdp)/(βbkq)(R 2 0 − 1). For computer simulation, we set the parameter values as the following: λ = 1 cell mm [27, 38] . Let τ 1 be the bifurcation parameter.
The disease-free equilibrium E 0 is now given by E 0 = (180, 0, 0, 0, 0), which is globally asymptotically stable from theorem 3. Further decreasing τ 1 to pass through the critical value τ d will cause E s to lose its stability, and give rise to the double-infection equilibrium, Then, we can obtain the characteristic equation Thus, D(ξ , τ 1 ) = 0 has a pair of purely imaginary roots at τ 1 = τ h , whose real parts become positive when τ 1 < τ h , implying existence of a Hopf bifurcation. At the critical point, τ 1 = τ h , E d loses its stability through a Hopf bifurcation, giving rise to limit cycles (figure 3). When τ 1 = τ h , we obtain
To sum up, the bifurcation diagram projected on y − τ 1 plane is given in figure 4 , which shows what impacts the delay τ 1 could have on the dynamics around the equilibria of model ( 
Discussion
In this paper, we propose an HIV model with a general nonlinear incidence rate and two time delays. Two production numbers R 0 and R z are obtained to determine the threshold properties. When R 0 < 1, the disease-free equilibrium E 0 = (x 0 , 0, 0, 0, 0) is globally asymptotically stable. When R 0 > 1, E 0 becomes unstable, and the single-infection equilibrium E s = (x s , y s , v s , 0, 0) occurs. When R 0 > 1 and R z < 1, E s is globally asymptotically stable. At shown that there exits an η > 0 such that lim inf t→∞ (z(t, φ), w(t, φ)) > (η, η) for φ ∈ X with φ 4 (0) > 0 and φ 5 (0) > 0 when R z > 1. From theorem 5.1 and numerical simulations, we can see that E d is asymptotically stable for R z ∈ (1, R b ), and there may exist a Hopf bifurcation at R z = R b . From the expression of R 0 , it is easy to see that ignoring either of two delays τ 1 and τ 2 leads to overestimation of the basic reproduction number R 0 . For the effects of delays on R z , we first need to study the derivatives of y s and v s with respect to τ 1 and τ 2 , respectively. From (2.4) and (2.5), we get the following equation figure 4 , it is easy to see that choosing different values for delays could change the dynamic behaviours, not only quantitatively, but also sometimes qualitatively. So intracellular delays should be included in the modelling of HIV infection. We should mention that some results (theorems 3.1 and 4.2) in this manuscript still hold if the system has no time delay or if function f is bilinear. The new dynamics is mainly derived with the introduction of the new variables z and w, see corollary 4.3. However, when we release some conditions, e.g. (1.5) for the nonlinear incidence function f , the system will become much more complicated, multiple steady-state solutions and multistabilities may exist. This is beyond the scope of this manuscript.
Note that systems (1.1) and (1.2) share the same basic reproduction number R 0 . When R 0 < R 1 , where R 1 is given in (2.13), E s is globally asymptotically stable in (1.2), just asẼ s in system (1.1), which means introducing the recombinant virus into the host cannot help to control the number of HIV in this case. When R 0 > R 1 , which is equivalent to R z > 1, the third equilibrium point E d comes into existence. From §2, we see x d > x s , y d < y s and v d < v s , implying that the virotherapy cannot only decrease HIV load and the number of infected cells by HIV, but also increase the healthy CD4 + T cell count. So when the recombinant virus can survive, i.e. R z > 1, it can help to control HIV infection.
Because R z can also be expressed in the form R z = y s /y d , the value of R z can be used to measure the performance of the virotherapy. Larger R z means more cells infected by HIV are killed and more health host cells are produced at E d . From numerical simulations we can see that there are some phenomena we should pay attention to when R z becomes larger. In figure 3 , as τ 1 becomes smaller, R z gets larger, and it takes more time for orbits to converge to E d , and the amplitude of oscillations also becomes larger. Furthermore, relative large R z may cause Hopf bifurcation. These two dynamics behaviours imply using this virotherapy may cause unsteadiness of the situation of patient using, if we do not choose the value range for R z carefully.
On the other hand, we have R z = (cαy s )/(bq), which is the mean number of recombinant virus caused by one recombinant virus when the number of single-infected cells stabilizes at y s . Obviously, R z is closely related to the parameters c, α, b and q in z and w equations. Although the explicit expression of y s cannot obtained from system (1.2) with general nonlinear incidence function f (x, v), we can see that y s is totally determined by system (1.1). In other words, y s is not affected with the varies of the recombinant virus w and double-infected cells z. Therefore, increasing c and α, or decreasing b and q can make R z larger. This would be very helpful to develop the virotherapy to meet our expectation.
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